Mechanistically, ceramides elicit inflammation-induced insulin resistance at least in part by activation of the Nod-like receptor (Nlrp3) inflammasome that induce caspase-1 cleavage in macrophages and adipose tissue, which thereon inhibits Akt/PKB activation and results in the development of insulin resistance (53). Here, NLRP3 is linked to Insulin resistance.